HIV/AIDS
Research results from Boston University, Medical Department update knowledge of HIV/AIDS
Published in AIDS Weekly, January 18th, 2010
"The purpose of this study was to test the hypothesis that inhibition of adipose lipolysis will retard atherogenic lesion development induced by the antiviral protease inhibitors. LDLR-null mice receiving ritonavir were compared with those receiving ritonavir plus lipolysis inhibitor acipimox or vehicle alone to determine how acipimox would affect ritonavir-induced atherogenesis. Intermittent high-fat...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2010-01-18)
More Articles from AIDS Weekly
- Johns Hopkins Medical Institutions
Early lessons from the H1N1 pandemic: Critical illness in children unpredictable but survivable - The Translational Genomics Research Institute
Circumcision associated with significant changes in bacteria - Acute Hepatitis
Studies from J. Dionneodom et al have provided new data on acute hepatitis - Anti-Infectives
Studies from University of Wurzburg provide new data on anti-infectives - Central Nervous System
Research reports on central nervous system from Temple University, Medical Department provide new insights - Cytomegalovirus Infection
Scientists at Chang-Gung University describe research in cytomegalovirus infection - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
